DOI QR코드

DOI QR Code

Risk factors for poor prognosis in nosocomial infective endocarditis

  • Hwang, Ji-won (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Seung Woo (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Cho, Eun Jeong (Department of Cardiology, National Cancer Center) ;
  • Lee, Ga Yeon (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Eun Kyoung (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chang, Sung-A (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Sung-Ji (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Sang-Chol (Division of Cardiology, Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, Cheol-In (Division of Infectious Disease, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chung, Doo Ryeon (Division of Infectious Disease, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Peck, Kyong Ran (Division of Infectious Disease, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Song, Jae-Hoon (Division of Infectious Disease, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2016.03.28
  • Accepted : 2016.08.23
  • Published : 2018.01.01

Abstract

Background/Aims: The aim of our study was to compare the characteristics of nosocomial infective endocarditis (NIE) with community-acquired infective endocarditis (CIE) and to determine independent risk factors for in-hospital death. Methods: We retrospectively reviewed the medical records of 560 patients diagnosed with infective endocarditis. NIE was defined by a diagnosis made > 72 hours after hospital admission or within 2 months of hospital discharge. Results: Among the 560 cases reviewed, 121 were classified as NIE. Compared with patients with CIE, patients with NIE were older ($mean{\pm}SD$, $51.30{\pm}18.01$ vs. $59.76{\pm}14.87$, p < 0.001). The in-hospital death rate of the NIE group was much higher than that of the CIE group (27.3% vs. 5.9%, p < 0.001). More patients with NIE had central intravenous catheters, and were undergoing hemodialysis (p < 0.001). Methicillin-resistant Staphylococcus aureus (MRSA) was the most common causal microorganism of NIE, and MRSA (p < 0.001) and fungus (p = 0.002) were more common in NIE compared with CIE. On multiple analysis, age, liver cirrhosis, cancer chemotherapy, central intravenous catheter, hemodialysis, and genitourinary tract manipulation were independent clinical risk factors for NIE. Among the patients with NIE, 33 died during their hospital admission. The independent risk factors for in-hospital death were older age (adjusted odds ratio [OR], 1.04; 95% confidence interval [CI], 1.01 to 1.07; p = 0.037) and chemotherapy for malignancy (adjusted OR, 3.89; 95% CI, 1.18 to 12.87; p = 0.026). Conclusions: Because of the considerable incidence of NIE and its poor prognosis, we should pay attention to early diagnosis and active management of NIE, especially for older patients and patients receiving chemotherapy.

Keywords

References

  1. Fefer P, Raveh D, Rudensky B, Schlesinger Y, Yinnon AM. Changing epidemiology of infective endocarditis: a retrospective survey of 108 cases, 1990-1999. Eur J Clin Microbiol Infect Dis 2002;21:432-437. https://doi.org/10.1007/s10096-002-0740-2
  2. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92:879-885. https://doi.org/10.1136/hrt.2005.067256
  3. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-2413. https://doi.org/10.1093/eurheartj/ehp285
  4. Castillo JC, Anguita MP, Ruiz M, et al. Changing epidemiology of native valve infective endocarditis. Rev Esp Cardiol 2011;64:594-598. https://doi.org/10.1016/j.recesp.2011.03.011
  5. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995;20:16-23. https://doi.org/10.1093/clinids/20.1.16
  6. Gouello JP, Asfar P, Brenet O, Kouatchet A, Berthelot G, Alquier P. Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases. Crit Care Med 2000;28:377-382. https://doi.org/10.1097/00003246-200002000-00015
  7. Gilleece A, Fenelon L. Nosocomial infective endocarditis. J Hosp Infect 2000;46:83-88. https://doi.org/10.1053/jhin.2000.0802
  8. Gregoratos G. Infective endocarditis in the elderly: diagnosis and management. Am J Geriatr Cardiol 2003;12:183-189. https://doi.org/10.1111/j.1076-7460.2003.02073.x
  9. Fernandez-Hidalgo N, Tornos Mas P. Epidemiology of infective endocarditis in Spain in the last 20 years. Rev Esp Cardiol (Engl Ed) 2013;66:728-733. https://doi.org/10.1016/j.recesp.2013.05.003
  10. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638. https://doi.org/10.1086/313753
  11. Martin-Davila P, Fortun J, Navas E, et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005;128:772-779. https://doi.org/10.1378/chest.128.2.772
  12. Fernandez-Hidalgo N, Almirante B, Tornos P, et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008;47:1287-1297. https://doi.org/10.1086/592576
  13. Durante-Mangoni E, Utili R. Nosocomial endocarditis: still a challenging diagnosis. Intern Emerg Med 2014;9:715-716. https://doi.org/10.1007/s11739-014-1105-4
  14. Kiefer TL, Bashore TM. Infective endocarditis: a comprehensive overview. Rev Cardiovasc Med 2012;13:e105-e120.
  15. Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, Siegman-Igra Y. Hospital-acquired infective endocarditis: should the definition be broadened? Clin Infect Dis 2004;38:843-850. https://doi.org/10.1086/381971
  16. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94. https://doi.org/10.1001/archinte.162.1.90
  17. Mouly S, Ruimy R, Launay O, et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002;45:246-256. https://doi.org/10.1053/jinf.2002.1058
  18. Giannitsioti E, Skiadas I, Antoniadou A, et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect 2007;13:763-769. https://doi.org/10.1111/j.1469-0691.2007.01746.x
  19. Lomas JM, Martinez-Marcos FJ, Plata A, et al. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 2010;16:1683-1690. https://doi.org/10.1111/j.1469-0691.2010.03043.x
  20. Nienaber JJ, Kusne S, Riaz T, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 2013;57:1438-1448. https://doi.org/10.1093/cid/cit536
  21. Nunez Aragon R, Pedro-Botet Montoya ML, Mateu Prunonosa L, et al. Associated factors and descriptive analysis of healthcare-related infective endocarditis in a tertiary reference hospital. Enferm Infecc Microbiol Clin 2013;31:15-22. https://doi.org/10.1016/j.eimc.2012.03.014
  22. Ruiz M, Sanchez MP, Dominguez JC, et al. Infective endocarditis in patients receiving chronic hemodialysis: clinical features and outcome. J Heart Valve Dis 2005;14:11-14.
  23. Farinas MC, Llinares P, Almirante B, et al. New trends in infective endocarditis. Enferm Infecc Microbiol Clin 2011;29 Suppl 4:22-35. https://doi.org/10.1016/S0213-005X(11)70033-7
  24. Peetermans WE, Hill EE, Herijgers P, et al. Nosocomial infective endocarditis: should the definition be extended to 6 months after discharge. Clin Microbiol Infect 2008;14:970-973. https://doi.org/10.1111/j.1469-0691.2008.02057.x
  25. Pujol M, Hornero A, Saballs M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect 2007;67:22-29. https://doi.org/10.1016/j.jhin.2007.06.017
  26. Hsu RB. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26:654-657. https://doi.org/10.1086/502597
  27. Benito N, Miro JM, de Lazzari E, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009;150:586-594. https://doi.org/10.7326/0003-4819-150-9-200905050-00004

Cited by

  1. Nosocomial Native Valve Endocarditis due to Methicillin-Susceptible Staphylococcus aureus in a Patient with Psoriatic Arthritis vol.66, pp.4, 2018, https://doi.org/10.2739/kurumemedj.ms664002
  2. Infective endocarditis: a retrospective cohort study vol.112, pp.9, 2018, https://doi.org/10.1093/qjmed/hcz134
  3. Nosocomial Vs. Community-Acquired Infective Endocarditis in Spain: Location, Trends, Clinical Presentation, Etiology, and Survival in the 21st Century vol.8, pp.10, 2018, https://doi.org/10.3390/jcm8101755
  4. Comparison Between Healthcare-Associated and Community-Acquired Infective Endocarditis at Tertiary Care Hospitals in Japan vol.84, pp.4, 2018, https://doi.org/10.1253/circj.cj-19-0887
  5. Infective endocarditis at a tertiary care hospital in South Korea vol.107, pp.2, 2018, https://doi.org/10.1136/heartjnl-2020-317265
  6. Infective Endocarditis and Its Short and Long-Term Prognosis in Hemodialysis Patients: A Systematic Review and Meta-analysis vol.46, pp.3, 2021, https://doi.org/10.1016/j.cpcardiol.2020.100680
  7. Infective endocarditis in patients with liver cirrhosis: a systematic review vol.33, pp.7, 2021, https://doi.org/10.1080/1120009x.2021.1878332
  8. Mural Endocarditis: The GAMES Registry Series and Review of the Literature vol.10, pp.4, 2021, https://doi.org/10.1007/s40121-021-00490-y
  9. Comparing Treatment Outcomes of Ampicillin-Sulbactam, Other β-Lactams, and Vancomycin in Blood Culture-Negative Infective Endocarditis vol.10, pp.12, 2018, https://doi.org/10.3390/antibiotics10121476